Evidence map›Paper›PMID 36414391›Full record

ArticleJournal of medical ethics2023

'VaxTax': a follow-up proposal for a global vaccine pandemic response fund.

Federico Germani, Felicitas Holzer, Ivette Ortiz, Nikola Biller-Andorno, Julian W März

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical ethics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Federico Germani *Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.
Felicitas Holzer *Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.
Ivette OrtizInstitute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.
Nikola Biller-AndornoInstitute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland.
Julian W MärzInstitute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland julian.maerz@ibme.uzh.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Equal access to vaccines has been one of the key ethical challenges during the COVID-19 pandemic. Most scholars consider the massive purchase and hoarding of vaccines by high-income countries, especially at the beginning of the pandemic, to be unjust towards the vulnerable living in low-income countries. A recent proposal by Andreas Albertsen of a vaccine tax has been put forward to remedy this problem. Under such a scheme, high-income countries would pay a contribution, conceptualised as a vaccine tax, dedicated to buying vaccines and distributing them to low and middle-income countries. Proceeding from this proposal, we critically assess the feasibility of a vaccine tax and suggest how to conceptualise and implement a vaccine tax in practice. We present our 'VaxTax model' and explore its comparative advantages and disadvantages while considering other possible measures to address the global vaccine access problem, also in view of future pandemics and disease outbreaks.

Indexed as

COVID-19Financial ManagementVaccinesFollow-Up StudiesHumansPandemicsVaccinesCOVID-19EthicsHealth Care Economics and Organizations

Identifiers

PMID36414391
PMCPMC9985762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.